Digest

Abstract Parkinson's disease research Lundbeck has announced a partnership with the Michael J Fox Foundation to pursue promising projects that may lead to novel treatments for Parkinson's disease. The charity is providing about $1 million to support the development of two projects. The first is a therapeutic antibody binding to alpha‐synuclein protein; animal models suggest that this may slow disease progression. The second project is novel research to develop a drug targeted at an orphan Gprotein coupled receptor not associated with dopamine function.
Source: Progress in Neurology and Psychiatry - Category: Neurology Tags: Digest Source Type: research